Daisuke Shintani
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 11
- Co-authors
- Keiichi Fujiwara (17 shared papers)Tadaaki Nishikawa (8 shared papers)Kosei Hasegawa (22 shared papers)Akira Yabuno (12 shared papers)Masanori Yasuda (7 shared papers)Sho Sato (9 shared papers)Eito Kozawa (1 shared paper)Mitsutake Yano (4 shared papers)
In The Last Decade
Daisuke Shintani
32 papers receiving 306 citations
Peers
Comparison fields: 5 of 43
- Reproductive Medicine 107
- Obstetrics and Gynecology 65
- Cancer Research 64
- Oncology 65
- Immunology 30
Countries citing papers authored by Daisuke Shintani
This map shows the geographic impact of Daisuke Shintani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Shintani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Shintani more than expected).
Fields of papers citing papers by Daisuke Shintani
This network shows the impact of papers produced by Daisuke Shintani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Shintani. The network helps show where Daisuke Shintani may publish in the future.
Co-authors
The 25 scholars most cited alongside Daisuke Shintani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 69 | |
| 2 | 2019 | 46 | |
| 3 | 2019 | 19 | |
| 4 | 2017 | 17 | |
| 5 | 2022 | 15 | |
| 6 | 2018 | 14 | |
| 7 | 2020 | 14 | |
| 8 | 2020 | 14 | |
| 9 | 2020 | 12 | |
| 10 | 2023 | 12 | |
| 11 | 2022 | 8 | |
| 12 | 2020 | 8 | |
| 13 | 2022 | 8 | |
| 14 | [Combination Therapy of Pregabalin with Tramadol for Treatment of Peripheral Neuropathy in Patients with Gynecological Cancer Receiving Taxane Containing Chemotherapy]. | 2017 | 8 |
| 15 | 2012 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2015 | 4 | |
| 18 | Obesity is a predictive biomarker of poor benefit from single-agent bevacizumab therapy in recurrent ovarian cancer patients. | 2022 | 3 |
| 19 | 2021 | 3 | |
| 20 | Acute pancreatitis induced by paclitaxel and carboplatin therapy in an ovarian cancer patient. | 2016 | 3 |
About Daisuke Shintani
Daisuke Shintani is a scholar working on Reproductive Medicine, Molecular Biology, Oncology, Immunology and Obstetrics and Gynecology, having authored 36 papers that have together received 308 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (11 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Treatment and Pharmacology (2 papers), Reproductive System and Pregnancy (2 papers), Immune Cell Function and Interaction (2 papers), Immunotherapy and Immune Responses (2 papers), Uterine Myomas and Treatments (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Reproductive Medicine (107 citations), Obstetrics and Gynecology (65 citations), Cancer Research (64 citations), Oncology (65 citations) and Immunology (30 citations). Daisuke Shintani has collaborated with scholars based in Japan, Singapore and Taiwan. Frequent co-authors include Keiichi Fujiwara, Tadaaki Nishikawa, Kosei Hasegawa, Akira Yabuno, Masanori Yasuda, Sho Sato, Eito Kozawa, Mitsutake Yano, Keisuke Watanabe and Yuji Ikeda. Their work appears in journals such as Annals of Oncology, Gynecologic Oncology, BMC Cancer, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.